Sublingual immunotherapy (SLIT) is safer than subcutaneous immunotherapy (SCIT) and this has lead to the reconsideration of the use of ultra-rush schedules for SLIT. The aim of this study was to assess the safety of ultra-rush SLIT in pollen-allergic children according to different timing of administration in relation to the pollen season.
|Numero di pagine||5|
|Rivista||Current Medical Research and Opinion|
|Stato di pubblicazione||Published - 2009|
All Science Journal Classification (ASJC) codes
La Grutta, S., Sieber, J., Frati, F., Di Cara, G., La Grutta, S., Sensi, L., Pajno, G., Incorvaia, C., Marcucci, F., Ariano, R., & Yacoub, M-R. (2009). Safety of sublingual immunotherapy started during the pollen season. Current Medical Research and Opinion, 25, 103-107.